Skip to main content

Table 3 Anthropometric measurements of male participants on ART

From: The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings

Variable

Lipoatrophy*

P-value**

Lipohypertrophy***

P-value**

With n = 12 Median [IQR]

Without n = 104 Median [IQR]

With n = 15 Median [IQR]

Without n = 101 Median [IQR]

Height (m)

1.7 [1.6-1.7]

1.7 [1.6-1.7]

0.942

1.7 [1.6-1.8]

1.7 [1.7-1.7]

0.954

Weight (kg)

65.5 [59.7-68.6]

63.5 [57.0-74.4]

0.895

67.4 [57.8-78.3]

62.7 [57.3-73.4]

0.408

BMI

23.3 [20.2-23.9]

22.4 [20.6-25.2]

0.772

23.6 [21.1-25.5]

22.3 [20.5-24.8]

0.324

Sagittal Abdominal Diameter (cm)

17.0 [16.0-19.5]

18.0 [17.0-20.0]

0.384

17.0 [16.0-22.0]

18.0 [17.0-20.0]

0.967

Circumferences

      

  Waist (cm)

81.75 [77–84.9]

80.4 [75.0-90.2]

0.953

83.8 [75.0-97.0]

79.8 [75.8-89.5]

0.338

  Hip (cm)

90 [87–93.5]

90.0 [85.0-97.0]

0.768

91.0 [85.0-97.0]

90.0 [85.0-96.0]

0.556

  Waist/hip ratio

0.89 [0.85-0.95]

0.91 [0.87-0.94]

0.740

0.93 [0.86-0.97]

0.90 [0.86-0.94]

0.325

  Mid-upper arm (cm)

27.0 [24–28.5]

26.0 [24.0-29.0]

0.877

27.0 [25.0-29.0]

26.0 [24.0-29.0]

0.817

  Mid-thigh (cm)

50.5 [43.5-52.5]

49.0 [46.0-54.0]

0.401

49.0 [46.0-56.0]

49.0 [46.0-54.0]

0.567

Skinfolds

      

  Bicep (mm)

3.9 [3.4-4.2]

3.5 [3.0-4.5]

0.329

4.1 [3.2-4.8]

3.5 [3.0-4.3]

0.180

  Tricep (mm)

6.8 [5.6-8.2]

6.4 [5.1-9.3]

0.921

8.4 [5.0-11.4]

6.4 [5.1-8.7]

0.444

  Abdomen (mm)

13.5 [10.5-16.9]

12.3 [8.5-30.1]

1.00

15.8 [9.3-28.2]

12.3 [8.5 -18.1]

0.309

  Thigh (mm)

8.4 [7.2-14.8]

8.5 [6.0-12.4]

0.490

13.5 [8.4-21.1]

8.1 [6.0-11.3]

0.008

  Sub-Scapular (mm)

9.4 [6.5-13.2]

8.3 [6.3-13.4]

0.605

10.5 [5.7-18.0]

8.2 [6.5-11.1]

0.770

  Supra-iliac (mm)

6.3 [4.4-6.8]

6.2 [4.9-9.4]

0.196

6.4 [4.7-12.1]

6.2 [4.9-8.5]

0.934

  Calf (mm)

5.5 [4.8-9.0]

5.8 [4.4-8.2]

0.739

6.8 [5.4-10.5]

5.5 [4.4-7.7]

0.094

  1. *based on patient report, those with moderate or severe fat loss in 2 or more regions.
  2. **Wilcoxon Rank-sum (Mann–Whitney) tests for continuous variables and chi-square tests for binary variables.
  3. ***based on patient report, those with moderate or severe fat gain in 2 or more regions.
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us